{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T04:21:40Z","timestamp":1762057300948,"version":"build-2065373602"},"reference-count":81,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EuroFlow Consortium","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]},{"name":"Bilateral Cooperation Program between Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior-CAPES (Bras\u00edlia\/Brazil)","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]},{"name":"Direcci\u00f3n General de Pol\u00edticas Universit\u00e1rias-Minist\u00e9rio de Educaci\u00f3n","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]},{"name":"Cultura y Deportes-DPGU (Madrid\/Spain)","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER-ONC; Instituto de Salud Carlos III, Ministerio de Econom\u00eda y Competitividad, Madrid, Spain and FONDOS FEDER)","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]},{"name":"PI (Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain and Fondos FEDER)","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro of Brazil","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico-CNPQ of Brazil","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]},{"name":"Instituto Desiderata\/Chevron, Rio de Janeiro, Brazil","award":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"],"award-info":[{"award-number":["311\/15","E26\/110.105\/2014","E26\/102.191\/2013","400194\/2014\u20137"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>For the last two decades, measurable residual disease (MRD) has become one of the most powerful independent prognostic factors in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, the effect of therapy on the bone marrow (BM) microenvironment and its potential relationship with the MRD status and disease free survival (DFS) still remain to be investigated. Here we analyzed the distribution of mesenchymal stem cells (MSC) and endothelial cells (EC) in the BM of treated BCP-ALL patients, and its relationship with the BM MRD status and patient outcome. For this purpose, the BM MRD status and EC\/MSC regeneration profile were analyzed by multiparameter flow cytometry (MFC) in 16 control BM (10 children; 6 adults) and 1204 BM samples from 347 children and 100 adult BCP-ALL patients studied at diagnosis (129 children; 100 adults) and follow-up (824 childhood samples; 151 adult samples). Patients were grouped into a discovery cohort (116 pediatric BCP-ALL patients; 338 samples) and two validation cohorts (74 pediatric BCP-ALL, 211 samples; and 74 adult BCP-ALL patients; 134 samples). Stromal cells (i.e., EC and MSC) were detected at relatively low frequencies in all control BM (16\/16; 100%) and in most BCP-ALL follow-up samples (874\/975; 90%), while they were undetected in BCP-ALL BM at diagnosis. In control BM samples, the overall percentage of EC plus MSC was higher in children than adults (p = 0.011), but with a similar EC\/MSC ratio in both groups. According to the MRD status similar frequencies of both types of BM stromal cells were detected in BCP-ALL BM studied at different time points during the follow-up. Univariate analysis (including all relevant prognostic factors together with the percentage of stromal cells) performed in the discovery cohort was used to select covariates for a multivariate Cox regression model for predicting patient DFS. Of note, an increased percentage of EC (&gt;32%) within the BCP-ALL BM stromal cell compartment at day +78 of therapy emerged as an independent unfavorable prognostic factor for DFS in childhood BCP-ALL in the discovery cohort\u2014hazard ratio (95% confidence interval) of 2.50 (1\u20139.66); p = 0.05\u2014together with the BM MRD status (p = 0.031). Further investigation of the predictive value of the combination of these two variables (%EC within stromal cells and MRD status at day +78) allowed classification of BCP-ALL into three risk groups with median DFS of: 3.9, 3.1 and 1.1 years, respectively (p = 0.001). These results were confirmed in two validation cohorts of childhood BCP-ALL (n = 74) (p = 0.001) and adult BCP-ALL (n = 40) (p = 0.004) treated at different centers. In summary, our findings suggest that an imbalanced EC\/MSC ratio in BM at day +78 of therapy is associated with a shorter DFS of BCP-ALL patients, independently of their MRD status. Further prospective studies are needed to better understand the pathogenic mechanisms involved.<\/jats:p>","DOI":"10.3390\/cancers14133088","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T21:25:00Z","timestamp":1656019500000},"page":"3088","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-4145","authenticated-orcid":false,"given":"Elen","family":"Oliveira","sequence":"first","affiliation":[{"name":"Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil"},{"name":"Cytometry Service, Instituto de Puericultura e Pediatria Martag\u00e3o Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-5816","authenticated-orcid":false,"given":"Elaine S.","family":"Costa","sequence":"additional","affiliation":[{"name":"Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil"},{"name":"Cytometry Service, Instituto de Puericultura e Pediatria Martag\u00e3o Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Ciudad","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Program, Centro de Investigaci\u00f3n del C\u00e1ncer and IBMCC (CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-5946","authenticated-orcid":false,"given":"Giuseppe","family":"Gaipa","sequence":"additional","affiliation":[{"name":"M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9384-914X","authenticated-orcid":false,"given":"\u0141ukasz","family":"Sedek","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Medical University of Silesia in Katowice (SUM), 41-808 Zabrze, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Barrena","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Program, Centro de Investigaci\u00f3n del C\u00e1ncer and IBMCC (CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5336-261X","authenticated-orcid":false,"given":"Tomasz","family":"Szczepanski","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice (SUM), 41-800 Zabrze, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Buracchi","sequence":"additional","affiliation":[{"name":"M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Silvestri","sequence":"additional","affiliation":[{"name":"Center of Biostatistics for Clinical Epidemiology, Department of Health Science, University of Milano-Bicocca, 20126 Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9379-0149","authenticated-orcid":false,"given":"Patr\u00edcia F. R.","family":"Siqueira","sequence":"additional","affiliation":[{"name":"Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil"},{"name":"Cytometry Service, Instituto de Puericultura e Pediatria Martag\u00e3o Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0303-3468","authenticated-orcid":false,"given":"Fabiana V.","family":"Mello","sequence":"additional","affiliation":[{"name":"Cytometry Service, Instituto de Puericultura e Pediatria Martag\u00e3o Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-612X","authenticated-orcid":false,"given":"Rafael C.","family":"Torres","sequence":"additional","affiliation":[{"name":"Cytometry Service, Instituto de Puericultura e Pediatria Martag\u00e3o Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo M. R.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Cytometry Service, Instituto de Puericultura e Pediatria Martag\u00e3o Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle V. C.","family":"Fay-Neves","sequence":"additional","affiliation":[{"name":"Cytometry Service, Instituto de Puericultura e Pediatria Martag\u00e3o Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Sonneveld","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-3763","authenticated-orcid":false,"given":"Vincent H. J.","family":"van der Velden","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC, (EMC) University Medical Center Rotterdam, Dr. Molewaterplein 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Mejstrikova","sequence":"additional","affiliation":[{"name":"Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, 15006 Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep-Maria","family":"Ribera","sequence":"additional","affiliation":[{"name":"Institut Catal\u00e0 d\u2019Oncologia-Hospital Germans Trias I Pujol, Josep Carreras Research Institute Badalona, Universitat Aut\u00f2noma de Barcelona, 08193 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentino","family":"Conter","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation\/ASST Monza, 20900 Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schrappe","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3650-7087","authenticated-orcid":false,"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-3167","authenticated-orcid":false,"given":"Marcelo G. P.","family":"Land","sequence":"additional","affiliation":[{"name":"Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-7230","authenticated-orcid":false,"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Program, Centro de Investigaci\u00f3n del C\u00e1ncer and IBMCC (CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14737140.2017.1347507","article-title":"New targeted therapies for relapsed pediatric acute lymphoblastic leukemia","volume":"17","author":"Pierro","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.18632\/oncotarget.23380","article-title":"Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia","volume":"9","author":"Boullosa","year":"2018","journal-title":"Oncotarget"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.stemcr.2017.04.019","article-title":"Detailed Characterization of Mesenchymal Stem\/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes","volume":"8","author":"Lavoie","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature13115","article-title":"Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia","volume":"508","author":"Li","year":"2014","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjh.13096","article-title":"Haematopoietic development and leukaemia in Down syndrome","volume":"167","author":"Roberts","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.2754","article-title":"A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2014-02-558833","article-title":"TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis","volume":"124","author":"Stengel","year":"2014","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/2040620713498161","article-title":"Genetic predispositions to childhood leukemia","volume":"4","author":"Stieglitz","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.exphem.2006.10.012","article-title":"Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia","volume":"35","author":"Blau","year":"2007","journal-title":"Exp. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2015-07-655100","article-title":"KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression","volume":"127","author":"Teodosio","year":"2016","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(00)02241-8","article-title":"Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells","volume":"355","author":"Gunsilius","year":"2000","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1084\/jem.20091050","article-title":"Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene","volume":"206","author":"Menendez","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00109-009-0583-8","article-title":"Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia","volume":"88","author":"Shalapour","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMc1500684","article-title":"Clonal hematopoiesis and blood-cancer risk","volume":"372","author":"Genovese","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24664","DOI":"10.18632\/oncotarget.8369","article-title":"Altered neutrophil immunophenotypes in childhood Bcell precursor acute lymphoblastic leukemia","volume":"7","author":"Oliveira","year":"2016","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.exphem.2006.01.013","article-title":"Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival","volume":"34","author":"Veiga","year":"2006","journal-title":"Exp. Hematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0145-2126(03)00188-7","article-title":"Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR)","volume":"28","author":"Sunnuqrut","year":"2004","journal-title":"Leuk. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","article-title":"Normal and leukemic stem cell niches: Insights and therapeutic opportunities","volume":"16","author":"Schepers","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/scd.2016.0295","article-title":"Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis","volume":"26","author":"Desbourdes","year":"2017","journal-title":"Stem Cells Dev."},{"key":"ref_24","first-page":"103","article-title":"Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches","volume":"12","author":"Konopleva","year":"2009","journal-title":"Drug Resist. Updates Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bjh.12883","article-title":"Disturbed CXCR4\/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia","volume":"166","author":"Willemse","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajh.23626","article-title":"Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene","volume":"89","author":"Chandia","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI30235","article-title":"Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase","volume":"117","author":"Iwamoto","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2006.06.8312","article-title":"Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial","volume":"25","author":"Ribera","year":"2007","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2016-07-726307","article-title":"Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia","volume":"129","author":"Theunissen","year":"2017","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood.2020007311","article-title":"Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia","volume":"137","author":"Ribera","year":"2021","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: Insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ng.2287","article-title":"The Pediatric Cancer Genome Project","volume":"44","author":"Downing","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12185-017-2262-9","article-title":"Complexity of bone marrow hematopoietic stem cell niche","volume":"106","author":"Asada","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbamcr.2015.08.015","article-title":"Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting","volume":"1863","author":"Chiarini","year":"2016","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2016.11.002","article-title":"Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia","volume":"46","author":"Churchman","year":"2017","journal-title":"Exp. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/pbc.25119","article-title":"Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance","volume":"61","author":"Vitanza","year":"2014","journal-title":"Pediatric Blood Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Conforti, A., Biagini, S., Del Bufalo, F., Sirleto, P., Angioni, A., Starc, N., Li Pira, G., Moretta, F., Proia, A., and Contoli, B. (2013). Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076989"},{"key":"ref_40","first-page":"43","article-title":"Effect of bFGF on HLA-DR expression of human bone marrow-derived mesenchymal stem cells","volume":"8","author":"Dighe","year":"2013","journal-title":"J. Stem Cells"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/leu.2008.361","article-title":"Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome","volume":"23","author":"Garcia","year":"2009","journal-title":"Leukemia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2011.08.030","article-title":"Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes","volume":"317","author":"Zhao","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cyto.b.20118","article-title":"Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow","volume":"70","author":"Jones","year":"2006","journal-title":"Cytometry. Part B Clin. Cytom."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.transproceed.2009.01.059","article-title":"Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry","volume":"41","author":"Martins","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13287-015-0152-8","article-title":"Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow","volume":"6","author":"Muniz","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1083\/jcb.136.2.421","article-title":"Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells","volume":"136","author":"Airas","year":"1997","journal-title":"J. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13287-017-0755-3","article-title":"High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: Identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources","volume":"9","author":"Amati","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jcb.10594","article-title":"Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection","volume":"89","author":"Baddoo","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1042\/BST20110745","article-title":"The emerging role of tetraspanin microdomains on endothelial cells","volume":"39","author":"Bailey","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.ATV.0000073832.49290.B5","article-title":"Endothelial progenitor cells: Mobilization, differentiation, and homing","volume":"23","author":"Hristov","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/sctm.19-0044","article-title":"Challenges in Clinical Development of Mesenchymal Stromal\/Stem Cells: Concise Review","volume":"8","author":"Mastrolia","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/10428190500144235","article-title":"Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes","volume":"46","author":"Cortelezzi","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fphys.2018.00556","article-title":"Circulating Endothelial Progenitor Cells Present an Inflammatory Phenotype and Function in Patients With Alcoholic Liver Cirrhosis","volume":"9","author":"Kaur","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cyto.b.20439","article-title":"Flow cytometric differential of leukocyte populations in normal bone marrow: Influence of peripheral blood contamination","volume":"76","author":"Brooimans","year":"2009","journal-title":"Cytometry. Part B Clin. Cytom."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jim.2016.12.006","article-title":"A simple flow-cytometry method to evaluate peripheral blood contamination of bone marrow aspirates","volume":"442","author":"Delgado","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood-2008-11-185132","article-title":"Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)","volume":"113","author":"Bassan","year":"2009","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children\u2019s Oncology Group study","volume":"111","author":"Borowitz","year":"2008","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group","volume":"339","author":"Cave","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","article-title":"Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia","volume":"351","author":"Behm","year":"1998","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute Lymphoblastic Leukemia in Children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/leu.2009.17","article-title":"Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol","volume":"23","author":"Corral","year":"2009","journal-title":"Leukemia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"Seriu","year":"1998","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1182\/blood-2015-03-633685","article-title":"Prognostic significance of minimal residual disease in high risk B-ALL: A report from Children\u2019s Oncology Group study AALL0232","volume":"126","author":"Borowitz","year":"2015","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bjh.13834","article-title":"Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia","volume":"172","author":"Ravandi","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/bcj.2013.31","article-title":"Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia","volume":"3","author":"Weng","year":"2013","journal-title":"Blood Cancer J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41375-020-01100-5","article-title":"Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting","volume":"35","author":"Modvig","year":"2021","journal-title":"Leukemia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1470-2045(15)70082-3","article-title":"Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: A prospective study","volume":"16","author":"Pui","year":"2015","journal-title":"Lancet. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/gcc.22882","article-title":"Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol","volume":"59","author":"Jung","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/bjh.13514","article-title":"The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013","volume":"170","author":"Olsson","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41598-020-58970-z","article-title":"Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia","volume":"10","author":"Gronroos","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"639013","DOI":"10.3389\/fonc.2021.639013","article-title":"Single-Cell Transcriptome Analysis Identifies Ligand-Receptor Pairs Associated With BCP-ALL Prognosis","volume":"11","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/10428194.2020.1832668","article-title":"Combined analysis of IKZF1 deletions and CRLF2 expression on prognostic impact in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"62","author":"Cui","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/s41375-020-0912-z","article-title":"Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols","volume":"34","author":"Popov","year":"2020","journal-title":"Leukemia"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/blood.V99.6.2179","article-title":"Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy","volume":"99","author":"Dias","year":"2002","journal-title":"Blood"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.exphem.2014.08.003","article-title":"Activation of the vascular niche supports leukemic progression and resistance to chemotherapy","volume":"42","author":"Poulos","year":"2014","journal-title":"Exp. Hematol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","article-title":"Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche","volume":"15","author":"Hanoun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Pezeshkian, B., Donnelly, C., Tamburo, K., Geddes, T., and Madlambayan, G.J. (2013). Leukemia Mediated Endothelial Cell Activation Modulates Leukemia Cell Susceptibility to Chemotherapy through a Positive Feedback Loop Mechanism. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060823"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/13\/3088\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:38:43Z","timestamp":1760139523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/13\/3088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":81,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["cancers14133088"],"URL":"https:\/\/doi.org\/10.3390\/cancers14133088","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2022,6,23]]}}}